0000000001109699

AUTHOR

Daniel Kraus

showing 6 related works from this author

Non‐bacterial thrombotic endocarditis in a patient with pancreatic carcinoma

2021

Nonbacterial thrombotic endocarditis (NBTE) is a rare condition that most often accompanies a malignant disease and involves a hypercoagulable state. We report the incidental finding of a rare case of an NBTE affecting the tricuspid valve in a patient with metastatic pancreatic carcinoma complicated by severe venous and arterial thromboembolisms.

Metastatic Pancreatic Carcinomamedicine.medical_specialtyTricuspid valvebusiness.industrymedicine.diseaseNonbacterial thrombotic endocarditisGastroenterologyMalignant diseasemedicine.anatomical_structureInternal medicineRare caseMedicineEndocarditisRadiology Nuclear Medicine and imagingPancreatic carcinomaCardiology and Cardiovascular MedicinebusinessEchocardiography
researchProduct

Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease

2018

Background Patients with chronic kidney disease ( CKD ) are at high risk of myocardial infarction. Cardiac troponins are the biomarkers of choice for the diagnosis of acute myocardial infarction ( AMI ) without ST ‐segment elevation ( NSTE ). In patients with CKD , troponin levels are often chronically elevated, which reduces their diagnostic utility when NSTE ‐ AMI is suspected. The aim of this study was to derive a diagnostic algorithm for serial troponin measurements in patients with CKD and suspected NSTE ‐ AMI . Methods and Results Two cohorts, 1494 patients from a prospective cohort study with high‐sensitivity troponin I (hs‐ cTnI ) measurements and 7059 cases from a clinical registr…

Malemedicine.medical_specialtyCardiac troponinNephrology and KidneyMyocardial InfarctionDiagnostic Testingmacromolecular substances030204 cardiovascular system & hematologynon‐ST‐segment elevation acute coronary syndromeurologic and male genital diseases03 medical and health sciences0302 clinical medicineTroponin TInternal medicinecohort studymedicineHumansProspective Studiescardiovascular diseasesddc:610030212 general & internal medicineMyocardial infarctionRenal Insufficiency ChronicOriginal ResearchAgedKidney in Cardiovascular Diseasebusiness.industryTroponin IMiddle AgedPrognosismedicine.diseasefemale genital diseases and pregnancy complicationsdecision aidsCardiologybiomarkerBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessAcute Coronary Syndromeschronic kidney diseaseBiomarkersFollow-Up StudiesGlomerular Filtration RateKidney diseaseCohort studyJournal of the American Heart Association
researchProduct

COVID-19—Importance for Patients on the Waiting List and after Kidney Transplantation—A Single Center Evaluation in 2020–2021

2021

(1) Background: Dialysis patients and recipients of a kidney allograft are at high risk for infection with SARS-CoV-2. It has been shown that the development of potent neutralizing humoral immunity against SARS CoV-2 leads to an increased probability of survival. However, the question of whether immunocompromised patients develop antibodies has not yet been sufficiently investigated; (2) Methods: SARS-CoV-2 antibodies were examined in hemodialysis patients on the waiting list for kidney transplantation as well as patients after kidney transplantation. Patients were interviewed about symptoms and comorbidities, BMI, and smoking history; (3) Results: SARS-CoV-2 antibodies were found in 16 out…

Microbiology (medical)medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.medical_treatmentkidney transplantationlcsh:MedicineCOVID-19; waiting list; hemodialysis; kidney transplantationSingle CenterArticleInternal medicinemedicineImmunology and AllergyMolecular BiologyKidney transplantationKidneyhemodialysisGeneral Immunology and Microbiologybiologybusiness.industrylcsh:RCOVID-19waiting listmedicine.diseaseVaccinationInfectious Diseasesmedicine.anatomical_structureHumoral immunitybiology.proteinHemodialysisAntibodybusinessPathogens
researchProduct

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outs…

2021

Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AK…

MalePhysiologymedicine.medical_treatmentLiver transplantationToxicologyPathology and Laboratory MedicineSeverity of Illness IndexBiochemistrylaw.inventionBlood Urea Nitrogen0302 clinical medicinelawLiver Cirrhosis AlcoholicMedicine and Health SciencesMedicineBileMultidisciplinaryLiver DiseasesQRMiddle AgedIntensive care unitBody FluidsRenal Replacement TherapyLiverCirrhosisNephrologyCreatinineMedicine030211 gastroenterology & hepatologyFemaleHemodialysisAnatomyDetoxificationResearch Articlemedicine.medical_specialtyCritical CareScienceSurgical and Invasive Medical ProceduresGastroenterology and Hepatology03 medical and health sciencesDigestive System ProceduresRenal DialysisIntensive careInternal medicineAlbuminsMedical DialysisHumansRenal replacement therapyDialysisRetrospective StudiesTransplantationbusiness.industryAcute-On-Chronic Liver FailureBiology and Life SciencesProteins030208 emergency & critical care medicineRetrospective cohort studyBilirubinOrgan TransplantationSurvival AnalysisLiver TransplantationPatient ComplianceLiver functionbusinessBiomarkersPLoS ONE
researchProduct

Urinary neutrophil gelatinase-associated lipocalin and cystatin C compared to the estimated glomerular filtration rate to predict risk in patients wi…

2016

Abstract Introduction Impaired renal function, reflected by estimated glomerular filtration rate (eGFR) or cystatin C, is a strong risk predictor in the presence of acute myocardial infarction (AMI). Urinary neutrophil gelatinase-associated lipocalin (uNGAL) is an early marker of acute kidney injury. uNGAL might also be a good predictor of outcome in patients with cardiovascular disease. Aim of the present study was to evaluate the prognostic value of uNGAL compared to eGFR and cystatin C in patients with suspected AMI. Methods 1818 patients were enrolled with suspected AMI. Follow-up information on the combined endpoint of death or non-fatal myocardial infarction was obtained 6months after…

Malemedicine.medical_specialtyUrinary systemMyocardial InfarctionRenal function030204 cardiovascular system & hematologyurologic and male genital diseasesCohort Studies03 medical and health sciences0302 clinical medicineLipocalin-2Predictive Value of TestsRisk FactorsInternal medicinemedicineClinical endpointHumans030212 general & internal medicineMyocardial infarctionCystatin CAgedAged 80 and overFramingham Risk Scorebiologybusiness.industryAcute kidney injuryMiddle Agedmedicine.diseaseCystatin Cbiology.proteinCardiologyFemaleCystatinCardiology and Cardiovascular MedicinebusinessBiomarkersFollow-Up StudiesGlomerular Filtration RateInternational journal of cardiology
researchProduct

Non-bacterial thrombotic endocarditis in a patient with pancreatic carcinoma

2021

610 Medical sciences610 Medizin
researchProduct